| 09 Feb, 07:19 pm | — | … | Aurobindo Pharma Limited has informed the Exchange regarding outcome of Board meeting held on February 09, 2026. | nse |
| 06 Feb, 06:19 pm | — | … | Aurobindo Pharma Limited has informed the Exchange about completion of US FDA Inspection at Unit III of Eugia Pharma Specialities Ltd., a wholly owned subsidiary company | nse |
| 02 Feb, 10:06 am | — | … | Aurobindo Pharma Limited has informed the Exchange regarding 'Submission of Clarification Significant Volume Movement in Company s Shares'. | nse |
| 01 Feb, 12:37 pm | — | … | Aurobindo Pharma Ltd - 524804 - Clarification sought from Aurobindo Pharma Ltd | bse |
| 31 Jan, 11:28 am | — | … | Aurobindo Pharma Limited has informed the Exchange regarding 'Clarification on Significant Volume Movement in Company s Shares sought vide letter No..:NSE/CM/Surveillance/16398 dated January 30, 2026. | nse |
| 31 Jan, 11:02 am | — | … | Significant increase in volume has been observed in Aurobindo Pharma Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Aurobindo Pharma Limited has submitted their response. | nse |
| 30 Jan, 06:28 pm | — | … | Significant increase in volume has been observed in Aurobindo Pharma Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited. | nse |
| 30 Jan, 04:43 pm | — | … | Aurobindo Pharma Ltd - 524804 - Board Meeting Intimation for Intimation Of Board Meeting Date | bse |
| 23 Jan, 05:15 pm | — | … | This is to inform you that Helix Healthcare B.V., a wholly owned subsidiary of the Company, has incorporated a new wholly owned subsidiary in Philippines by the name of Aurobindo Pharma Philippines Inc. on 23rd January 2026. | nse |
| 23 Jan, 05:09 pm | — | … | Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Acquisition | bse |
| 09 Jan, 03:19 pm | — | … | Aurobindo Pharma Ltd - 524804 - Curateq Biologics Receives NOC From Health Canada For Its Biosimilar Dyrupeg | bse |
| 09 Jan, 03:18 pm | — | … | Aurobindo Pharma Limited has informed the Exchange about receipt of Notice of Compliance from Health Canada for Dyrupeg biosimilar | nse |
| 01 Jan, 06:05 pm | — | … | Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Acquisition | bse |
| 01 Jan, 06:02 pm | — | … | Aurobindo Pharma Limited has informed the Exchange about acquisition of the branded non-oncology prescription formulations business of Khandelwal Laboratories Private Limited as a going concern, including without limitation inventory, intellectual property, employees, contracts etc. on a slump sale basis is being acquired by Auro Pharma Limited, a wholly owned subsidiary of the Company. | nse |
| 30 Dec, 11:23 am | — | … | Aurobindo Pharma Limited has informed the Exchange about update on acquisition of 26% stake in Swarnaakshu Solar Power Private Limited | nse |
| 30 Dec, 11:15 am | — | … | Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Updates on Acquisition | bse |
| 27 Dec, 11:58 am | — | … | Aurobindo Pharma Limited has informed the Exchange about General Updates | nse |
| 27 Dec, 11:54 am | — | … | Aurobindo Pharma Ltd - 524804 - Curateq Biologics Private Limited, A Wholly Owned Subsidiary Of The Company Has Mutually Agreed To Terminate Its Agreement With Biofactura Inc, USA | bse |
| 23 Dec, 01:28 pm | — | … | Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Acquisition | bse |
| 23 Dec, 01:28 pm | — | … | Aurobindo Pharma Limited has informed the Exchange about acquisition of additional 20% stake in Luoxin Aurovitas Pharma (Chengdu) Co. Ltd, China, a joint venture company | nse |
| 18 Dec, 10:05 am | — | … | Aurobindo Pharma Limited has informed the Exchange about completion of US FDA Inspection at Unit-IV of APL Healthcare Limited, a wholly owned subsidiary of the Company | nse |
| 12 Dec, 05:12 pm | — | … | Aurobindo Pharma Limited has informed the Exchange about completion of US FDA Inspection at Unit-V of Apitoria Pharma Private Limited, a wholly owned subsidiary of the Company | nse |
| 14 Nov, 04:06 pm | — | … | Aurobindo Pharma Ltd - 524804 - Completion Of US FDA Inspection At Unit II Of Eugia Pharma Specialities Ltd., Bhiwadi, A Wholly Owned Subsidiary Of The Company | bse |
| 14 Nov, 04:06 pm | — | … | Aurobindo Pharma Limited has informed the Exchange about completion of US FDA Inspection at Unit II of Eugia Pharma Specialities Ltd. | nse |
| 14 Nov, 10:41 am | — | … | Aurobindo Pharma Limited has informed the Exchange about classification of US FDA Inspection at Unit-I of Apitoria Pharma Private Limited as VAI | nse |
| 11 Nov, 05:01 pm | — | … | Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | bse |
| 11 Nov, 05:00 pm | — | … | Aurobindo Pharma Limited has informed the Exchange about Transcript | nse |
| 07 Nov, 02:13 pm | — | … | Aurobindo Pharma Limited has informed the Exchange about Copy of Newspaper Publication of its second quarter financial results | nse |
| 05 Nov, 08:03 pm | — | … | Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 05 Nov, 08:02 pm | — | … | Aurobindo Pharma Limited has informed the Exchange regarding a press release dated November 05, 2025, titled "Press Release". | nse |
| 05 Nov, 08:00 pm | — | … | Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Investor Presentation | bse |
| 05 Nov, 07:59 pm | — | … | Aurobindo Pharma Limited has informed the Exchange about Investor Presentation | nse |
| 05 Nov, 07:55 pm | — | … | Aurobindo Pharma Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025. | nse |
| 05 Nov, 07:52 pm | — | … | Aurobindo Pharma Ltd - 524804 - Board Meeting Outcome for Outcome Of The Board Meeting Held On November 5, 2025 | bse |
| 04 Nov, 12:57 pm | — | … | Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Change in Management | bse |
| 04 Nov, 12:55 pm | — | … | Aurobindo Pharma Limited has informed the Exchange about change in Senior Management personnel | nse |
| 30 Oct, 03:24 pm | — | … | Aurobindo Pharma Limited has informed the Exchange regarding 'Clarification on movement in volume'. | nse |
| 30 Oct, 03:23 pm | — | … | Aurobindo Pharma Ltd - 524804 - Clarification With Reference To Movement In Volume. | bse |
| 30 Oct, 02:41 pm | — | … | Aurobindo Pharma Ltd - 524804 - Clarification sought from Aurobindo Pharma Ltd | bse |
| 24 Oct, 04:05 pm | — | … | Aurobindo Pharma Ltd - 524804 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On November 5, 2025 For Consideration Unaudited Financial Results For The Second Quarter & Half Year Ended On September 30, 2025. | bse |
| 23 Oct, 09:53 am | — | … | Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Acquisition | bse |
| 23 Oct, 09:50 am | — | … | Aurobindo Pharma Limited has informed the Exchange about Incorporation of a step down subsidiary in Chile viz Eugia Pharma Chile SpA | nse |
| 23 Oct, 09:49 am | — | … | Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Acquisition | bse |
| 23 Oct, 09:48 am | — | … | Aurobindo Pharma Limited has informed the Exchange about Incorporation of a step down subsidiary viz Aurobindo Pharma Chile SpA | nse |
| 01 Oct, 12:19 pm | — | … | Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Change in Management | bse |
| 01 Oct, 12:13 pm | — | … | Aurobindo Pharma Limited has informed the Exchange regarding resignation of Mr S. Venkatesh Kumar as Associate Vice President of the Company w.e.f. October 01, 2025. | nse |
| 01 Oct, 12:00 pm | — | … | Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Updates on Acquisition | bse |
| 01 Oct, 11:58 am | — | … | Aurobindo Pharma Limited has informed the Exchange about Acquisition | nse |
| 26 Sept, 06:14 pm | — | … | Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Acquisition | bse |
| 26 Sept, 06:10 pm | — | … | Aurobindo Pharma Limited has informed the Exchange about incorporation of CuraTeQ Biologics (Malta) Limited | nse |